|
Sign In to gain access to subscriptions and/or personal tools.
|
Pitfalls Associated With Antibiograms
Edward H. Eiland III, PharmD, MBA, BCPS, CGP*,
Christopher Ryan Dunne, PharmD,
and
William Lindgren, MT (ASCP)
* To whom correspondence should be addressed. E-mail: edwar017{at}hhsys.org.
 |
Abstract |
|---|
An accurate, appropriately collated antibiogram represents an integral resource for health care providers when assessing bacterial resistance and guiding antimicrobial selection and formulary decisions. Interpretation of bacterial susceptibility statistics is problematic yet frequent and unrecognized pitfalls may be avoided by following the M39-A2 guidelines to ensure correct analysis and presentation of cumulative antimicrobial susceptibility test data. This review addresses guideline recommendations related to antibiogram development, CLSI breakpoint interpretation, antimicrobial inclusion decisions, and the avoidance of duplicate and surveillance isolates. Unit-specific antibiograms in critical care units is encouraged for differentiation between hospital-wide ecology and these specific areas harboring more resistant pathogens. Antibiograms cannot track the emergence of microbial resistance during therapy and discrepancies exist between automated microbiology surveillance systems and their agreement with manual surveillance methods. When striving to improve overall patient outcomes, the use of a well-produced and disseminated antibiogram helps guide clinical decision making for patients requiring antimicrobial therapy.
First published on August 26, 2008, doi:10.1177/0897190008318500
Journal of Pharmacy Practice 2008;21:319.
A more recent version of this article appeared on October 1, 2008
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
